Department of  Neurosurgery
Menu  -
Call Us: (314) 362-3636

Christopher Dibble, MD, PhD

Position: PGY3
Hometown:  Raleigh, NC
Medical School: University of North Carolina at Chapel Hill
Undergraduate: Duke University

Clinical/Research Interests: Cerebrovascular, endovascular, minimally invasive neurosurgery. Cell signaling, pharmacology, vascular biology.


  • Ruptured Arteriovenous Malformation Presenting with Kernohan's Notch. Dibble CF, Wemhoff MP, Ibrahim T, Sasaki-Adams D, Solander S, Germanwala AV. Case Rep Neurol Med. 2015;2015:921930. doi: 10.1155/2015/921930. Epub 2015 Apr 27.
  • Role of cytoskeletal proteins in cerebral cavernous malformation signaling pathways: a proteomic analysis. Baxter SS, Dibble CF, Byrd WC, Carlson J, Mack CR, Saldarriaga I, Bencharit S. Mol Biosyst. 2014 Jul;10(7):1881-9. doi: 10.1039/c3mb70199a.
  • Systems biology and proteomic analysis of cerebral cavernous malformation. Edelmann AR, Schwartz-Baxter S, Dibble CF, Byrd WC, Carlson J, Saldarriaga I, Bencharit S. Expert Rev Proteomics. 2014 Jun;11(3):395-404. doi: 10.1586/14789450.2014.896742. Epub 2014 Mar 31.
  • Cerebral cavernous malformation is a vascular disease associated with activated RhoA signaling. Richardson BT, Dibble CF, Borikova AL, Johnson GL. Biol Chem. 2013 Jan;394(1):35-42. doi: 10.1515/hsz-2012-0243. Review.